Clinical Significance of the Highest Regional Bone Scan Index in Patients with Metastatic Castration–Resistant Prostate Cancer

[1]  H. Miyashita,et al.  Risk factors of skeletal-related events in patients with bone metastatic castration-resistant prostate cancer undergoing treatment with zoledronate , 2021, Supportive Care in Cancer.

[2]  A. Okizaki,et al.  The utility of a deep learning-based algorithm for bone scintigraphy in patient with prostate cancer , 2020, Annals of Nuclear Medicine.

[3]  M. Kreissl,et al.  Analysis of Bone Scans in Various Tumor Entities Using a Deep-Learning-Based Artificial Neural Network Algorithm—Evaluation of Diagnostic Performance , 2020, Cancers.

[4]  S. Egawa,et al.  Risk stratification for the prediction of overall survival could assist treatment decision‐making at diagnosis of castration‐resistant prostate cancer: a multicentre collaborative study in Japan , 2020, BJU international.

[5]  Jie Jin,et al.  Prognostic value of the bone scan index in patients with metastatic castration-resistant prostate cancer: a systematic review and meta-analysis , 2020, BMC Cancer.

[6]  A. Briganti,et al.  Development of a prognostic model for survival time prediction in castration-resistant prostate cancer patients. , 2020, Urologic oncology.

[7]  Atsushi Saito,et al.  Automated measurement of bone scan index from a whole-body bone scintigram , 2019, International Journal of Computer Assisted Radiology and Surgery.

[8]  Lars Edenbrandt,et al.  Phase 3 Assessment of the Automated Bone Scan Index as a Prognostic Imaging Biomarker of Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer: A Secondary Analysis of a Randomized Clinical Trial , 2018, JAMA oncology.

[9]  M. Yao,et al.  Prognostic Value of Automated Bone Scan Index in Men With Metastatic Castration‐resistant Prostate Cancer Treated With Enzalutamide or Abiraterone Acetate , 2017, Clinical genitourinary cancer.

[10]  Yongsheng Song,et al.  Prognostic value of bone scan index as an imaging biomarker in metastatic prostate cancer: a meta-analysis , 2017, Oncotarget.

[11]  L. Edenbrandt,et al.  Bone scan index: A new biomarker of bone metastasis in patients with prostate cancer , 2017, International journal of urology : official journal of the Japanese Urological Association.

[12]  A. Alva,et al.  Clinical Correlates of Benefit From Radium‐223 Therapy in Metastatic Castration Resistant Prostate Cancer , 2017, The Prostate.

[13]  Mattias Ohlsson,et al.  Analysis of regional bone scan index measurements for the survival of patients with prostate cancer , 2014, BMC Medical Imaging.

[14]  T. Ueda,et al.  Prognostic significance of bone metastases in patients with metastatic prostate cancer , 1993, Cancer.

[15]  D. Byar,et al.  Quantitative radiology for staging and prognosis of patients with advanced prostatic carcinoma. Correlations with other pretreatment characteristics. , 1979, Urology.